Adaptive exchange sustains cullin–RING ubiquitin ligase networks and proper licensing of DNA replication

Author:

Zhang Yaru1,Jost Marco234,Pak Ryan A.234,Lu Daniel5,Li Jing1,Lomenick Brett6,Garbis Spiros D.6,Li Chi-Ming5,Weissman Jonathan S.234,Lipford James Russell1,Deshaies Raymond J.78ORCID

Affiliation:

1. Oncology Research, Amgen Research, Thousand Oaks, CA 91320

2. Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158

3. California Institute for Quantitative Biosciences, University of California, San Francisco, CA 94158

4. HHMI, University of California, San Francisco, CA 94158

5. Genome Analysis Unit, Amgen Research, South San Francisco, CA, 94080

6. Proteome Exploration Laboratory, Beckman Institute, California Institute of Technology, Pasadena, CA 91125

7. Amgen Research, Thousand Oaks, CA 91320

8. Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125

Abstract

Cop9 signalosome (CSN) regulates the function of cullin–RING E3 ubiquitin ligases (CRLs) by deconjugating the ubiquitin-like protein NEDD8 from the cullin subunit. To understand the physiological impact of CSN function on the CRL network and cell proliferation, we combined quantitative mass spectrometry and genome-wide CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) screens to identify factors that modulate cell viability upon inhibition of CSN by the small molecule CSN5i-3. CRL components and regulators strongly modulated the antiproliferative effects of CSN5i-3, and in addition we found two pathways involved in genome integrity, SCF FBXO5 –APC/C–GMNN and CUL4 DTL –SETD8, that contribute substantially to the toxicity of CSN inhibition. Our data highlight the importance of CSN-mediated NEDD8 deconjugation and adaptive exchange of CRL substrate receptors in sustaining CRL function and suggest approaches for leveraging CSN inhibition for the treatment of cancer.

Funder

HHS | NIH | National Cancer Institute

Howard Hughes Medical Institute

Amgen

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3